PITX2 and ovarian carcinoma: Similarly, comparing RGS expression in normal versus tumor tissue using existing databases reveals significant changes in RGS expression during ovarian cancer progression, suggesting RGS expression levels are altered as ovarian epithelial cells undergo oncogenic transformation [13].